I-DUBLIN, nge-26 kaJuni, ngo-2023- INgxelo "Intengiso yeziyobisi yePeptide ethintelweyo-uHlahlelo lweHlabathi kunye neNgingqi: Gxininisa kwiintlobo zePeptide, iMveliso kunye noHlahlelo lweNgingqi-Uhlahlelo kunye noQoqosho, 2024-2040".
Emva kokuqaliswa kwentengiso yokuqala yechiza le-peptide elithintelweyo, imarike yamachiza ethintelweyo yehlabathi kuqikelelwa ukuba iza kukhula ukusuka ngo-2024 ukuya ku-2040. ixesha loqikelelo luka-2025-2040.
Imakethi ye-peptide ethintelweyo yehlabathi kulindeleke ukuba ibe nokukhula okumangalisayo ngexesha loqikelelo ukusuka kowama-2025 ukuya kowama-2040, oluqhutywa ubukhulu becala sisithembiso sombhobho omtsha othintelweyo wepeptide ongasaphelelanga ekujoliswe kuko kwi-receptor.Inkqubela phambili kwitekhnoloji yekhemikhali, inkqubela phambili ekurhwebeni konyango lwepeptide yokwenziwa kwiminyaka yamva nje, kunye namaxabiso afikelelekayo aphunyezwe zezi biomolecules kwizifo ezahlukeneyo zezinye izinto ezongezelelekileyo ezinegalelo ekukhuleni okuqikelelweyo kwixesha eliqikelelwayo.
Uhlalutyo lweempembelelo zexesha elifutshane kunye nexesha elide lwenziwa kwizinto ezichaphazela kakhulu imarike, ezizezi, abaqhubi, izithintelo kunye namathuba.Uvavanyo lwexesha elifutshane luqwalasela ixesha le-2020-2025 kunye novavanyo lwexesha elide luqwalasela ixesha le-2026-2040.
Uphuhliso oluphambili kunye nezicwangciso ezamkelwe ngabanye babadlali abaphambili kule marike zibandakanyiwe kuvavanyo lohlalutyo lwempembelelo.Ukongeza, olu phuhliso luphambili luyavavanywa ukuze kuqondwe amathuba exesha elizayo okudibanisa itekhnoloji ephezulu ukuphumeza iziphumo eziphezulu.Ukongeza, ukuvunywa kunye nokuqaliswa kweenkampani kunye neearhente zelungelo elilodwa lomenzi wechiza nazo zithathelwa ingqalelo xa kuvavanywa amandla orhwebo lwehlabathi lwamachiza epeptide anemiqathango yepeptide.
Izinto eziBangayo kunye nezithintelo Oku kulandelayo zizinto ezibangwayo kwimarike yehlabathi yePeptide Dependence Inhibitors:
4 Isishwankathelo seMarike 4.1 Intshayelelo 4.1.1 Ubume kunye noYilo lwePeptides eMiselweyo 4.1.2 Iindidi zePeptides eMiselweyo 4.2 Ukuvela kweePeptides eziThintelweyo 4.3 Uphuhliso lweePeptides eziThintelweyo njengamachiza 4.4 IiNdawo zoNyango ezinokwenzeka 4.5 ISingqinisiso esiPhambili 4. ) ) 4.7 Iintsingiselo zeshishini ezingundoqo kwindlela yokwazisa 4.8 Iintsingiselo eziphambili kushishino – inkqubela phambili yobuchwepheshe 4.9 Ubungakanani bemarike yangoku kunye namandla okukhula, i-USD yeebhiliyoni, ngo-2024-2040 kunye nohlaziyo lweenkampani ezivelisa amachiza epeptide okuthintelweyo
5 Iipropathi zeepeptides ezithintelwe ngokomgaqo 5.1 Iipropati zeepeptides ezithintelweyo 5.2 Ukuhlanganiswa kweepeptides ezithintelweyo 5.2.1 Ikhemikhali ligation yeepeptides kunye nokubopha ibridging 5.2.2 Chemical ligation yeepeptides ukuya kwizikafula (CLIPS) 5.2.3 I-Crosslinking ye-peptide ye-peptide.2. ukubhaqwa (5.2.5 Liquid-Phase Peptide Synthesis (LPPS) 5.2.6 Solid-Phase Peptide Synthesis (SPPS) 5.3 Inkqubela phambili kwiPeptide Technology 5.3.1 Peptide Synthesis Ngokusebenzisa iMicrofluidics 5.3.2 IsiGaba esiSolid sePeptide Synthesis5 Ukusebenzisa iMicrowaves eSine Khetha Isixokelelwano
6 Iinkcukacha zoShishino 6.1 Isishwankathelo 6.2 Imiba eVunywe ngokuLawulwayo Iindlela zeePeptides eziMiselweyo 6.3 Iimeko zoLawulo lweePeptides eziThintelweyo 6.4 Iimfuneko zoLawulo lwase-US kunye noLwakhiwo 6.4.1 uGunyaziso lwezoNyango 6.4.2 Ugunyaziso lwezoNyango 6.4.2 Ugunyaziso lwe-FDA4.4 IsiGunyaziso se-FDA4. umgaqo 6.5 Iimfuneko zomthetho zaseYurophu kunye nesakhelo 6.5.1 Inkqubo yesicelo selayisensi ye-EMA 6.5.2 Iinkqubo ezibekwe kwindawo ephakathi 6.5.3 Iinkqubo zokwahlula 6.5.4 Iinkqubo zokuqaphela okuhlangeneyo 6.5.5 Iinkqubo zeSizwe 6.6 Iimfuno zomthetho kunye nezicwangciso kwingingqi ye-Asia-Pacific 6.6.1 Iimfuno zomthetho kunye nolwakhiwo eJapan 6.7 Iimeko zembuyekezo 6.7.1 Iimeko zembuyekezo yesifo esizimelayo 6.7.2 Iimeko zembuyekezo yomhlaza 6.7.3 Iimeko zembuyekezo yesifo esinqabileyo
7 Uguqulo lweMakethi 7.1 Uhlalutyo lwempembelelo 7.2 Imiba yeMarike 7.2.1 Ukwandiswa kokuDityaniswa kokuDityaniswa kunye nokuThatha iiSellula 7.2.2 Uphuhliso lweNdlela eziNcinciweyo zeSynthetic 7.2.3 Ukunyinwa kweePeptides eziqhelekileyo 7.2.4 Ukunyuka kweNkxaso-mali kaRhulumente kunye neNgxowa-mali yaBucala 7.2. .4 .2 Ukuxhaswa ngemali ziinkampani ezidwelisiweyo 7.2.4.3 Inkxaso-mali ngamaziko karhulumente 7.3 Izithintelo zemarike 7.3.1 Ukwanda kokhuphiswano lwebhayoloji 7.3.2 Umngcipheko weziphumo zokhuselo lomzimba kunye neepropathi ezigqwesileyo zeADME 7.4 Amathuba emarike 7.4.1 Ukuncipha kweepeptides ekufumaneni ichiza 7.4.2 Izicelo ezahlukeneyo inkqubo luvo kunye nonyango lomhlaza
8 Imbonakalo-mhlaba enokhuphiswano 8.1 Isishwankathelo somhlaba wokhuphiswano 8.1.1 Uphuhliso oluphambili 8.1.2 Imisebenzi yolawulo nezomthetho 8.1.3 Ukudityaniswa nokufunyanwa 8.1.4 Imisebenzi yentsebenziswano 8.1.5 Imisebenzi yezemali 8.1.6 Uphuhliso lwezonyango 8.1.6 Uphuhliso lwezonyango
9 Imarike yehlabathi jikelele yokunqanda iziyobisi ze-peptide (ngokwemiyalelo), mln USD, 2024–2040 9.1 Uyilo loLwango lweKlinikhi lokuThintela uNyango lwePeptide 9.1.1 Unyango olunokubakho lweSigaba II) 9.1.2.3 UkuSebenza, uKhuseleko, kunye neDatha yokunyamezela (Inqanaba 1) 9. .2.4 Izifundo ezingezizo ezonyango ze-BT5528 9.1.3 PN-9439.1.3.1 Intshayelelo yeMveliso 9.1.3.2 Izifundo zokuyila (iSigaba 2) 9.1.3.3 Ukusebenza, ukhuseleko kunye nedatha yokunyamezela (iSigaba II) 9.1.4 PN-2319.1.4 Imveliso yePN-2319.1.4. 4.2 Uyilo lophononongo (iSigaba IIb) 9.1.4.3 Ulwazi olusebenzayo, ukhuseleko kunye nokunyamezela (iSigaba IIb) 9.1.5 Rusfertide (PTG-300) 9.1.5.1 Isishwankathelo semveliso 9.1.5.2 Uyilo lophononongo (Isigaba II) 9.1.5.3 Ukusebenza, ukhuseleko kunye nokhuseleko idatha yokunyamezela (iSigaba IIa) 9.1.6 Amachiza anokubakho kwiSigaba sesi-III 9.1.7 Zilukoplan (RA101495) 9.1.7.1 Isishwankathelo semveliso 9.1.7.2 Uyilo lophononongo (iSigaba sesi-III) 9.1.7.3 Ulwazi olusebenzayo, ukhuseleko nokunyamezela (iSigaba III.7.7.) 49. Iprofayili ye-Pharmacokinetic kunye ne-pharmacodynamic ye-Zilucoplan (iSigaba I) 9.1.8 Rusfertide (PTG- 300) 9.1.8.1 Isishwankathelo semveliso 9.1.8.2 Uyilo lokufunda (iSigaba III) 9.1.8.3 Ukuphumelela, ukhuseleko kunye nedatha yokunyamezela (Isigaba II) 9.2 Uhlalutyo lwe-9.2 Amandla ophuhliso lwemarike yehlabathi yamachiza epeptide athintelweyo, i-USD yezigidi, impumelelo ka-2024-2040 9.2.2.2 Iindleko zemveliso ye-API (CDMO)
I-10 Imarike yehlabathi jikelele yamachiza anesenzo se-peptide esilinganiselweyo (ngohlobo lwe-peptide), i-US $ mln, 2024-2040 i-peptide edibeneyo (DRP))
11 Imarike yehlabathi jikelele yamachiza epeptide ethintelweyo (ngeemveliso ezinokubakho), mln USD, 2024–2040 (RA101495) 11.1.2.1 API imveliso (yasekhaya) 11.1.2.2 API imfuno forecast for 2024-2040 11.1.3 Rusfertide-301 (Rusfertide) .3.1 Ukuveliswa kwe-API (Ukukhutshwa ngaphandle) Iindleko 11.1.4 PN-94311.1.4.1 Imveliso ye-API (Ukukhutshwa ngaphandle) 11.1.4.2 I-API Demand Forecast 2024-2040
Ixesha lokuposa: Jul-06-2023